Diagnostics News and Research

RSS
EKF Diagnostics to introduce upgraded POC analyzer and new sTNFr1 test kit at Medica 2013

EKF Diagnostics to introduce upgraded POC analyzer and new sTNFr1 test kit at Medica 2013

Pregnant women who receive allergy shots may decrease baby's chance of developing allergies

Pregnant women who receive allergy shots may decrease baby's chance of developing allergies

UCLA launches first university-based military medicine center to care for wounded veterans

UCLA launches first university-based military medicine center to care for wounded veterans

Diagnostic technology advancing but barriers prevent integration into care, IDSA report warns

Diagnostic technology advancing but barriers prevent integration into care, IDSA report warns

Atherotech Diagnostics Lab announces opening of patient service center in Sarasota, FL

Atherotech Diagnostics Lab announces opening of patient service center in Sarasota, FL

New 4th generation HIV assays now available to improve screening for HIV infection

New 4th generation HIV assays now available to improve screening for HIV infection

Advanced prostate cancer therapies: an interview with Dr. Nancy Dawson, Lombardi Comprehensive Cancer Center

Advanced prostate cancer therapies: an interview with Dr. Nancy Dawson, Lombardi Comprehensive Cancer Center

SRI International awarded NIDA contract to study new treatment therapies for substance abuse

SRI International awarded NIDA contract to study new treatment therapies for substance abuse

Physicians' Education Resource to host 11th Annual School of Breast Oncology in Atlanta, GA

Physicians' Education Resource to host 11th Annual School of Breast Oncology in Atlanta, GA

One Lambda gets CE mark approval in Europe for C1qScreen assay

One Lambda gets CE mark approval in Europe for C1qScreen assay

Ventana partners with Incyte to develop companion diagnostic tests for oncology drug programs

Ventana partners with Incyte to develop companion diagnostic tests for oncology drug programs

Life Technologies revenue for third quarter increases 3% to $936

Life Technologies revenue for third quarter increases 3% to $936

Bruker to hold NMR webinar in late November

Bruker to hold NMR webinar in late November

AMP 2013 to focus on genomics, proteomics, informatics, reimbursement and optimization of patient care

AMP 2013 to focus on genomics, proteomics, informatics, reimbursement and optimization of patient care

Offspring born to stressed mothers show stress-induced changes

Offspring born to stressed mothers show stress-induced changes

Zevacor Molecular buys 70 MeV Cyclotron dedicated to medical use from IBA

Zevacor Molecular buys 70 MeV Cyclotron dedicated to medical use from IBA

Polyphor, Roche agree to develop and commercialize antibiotic for bacterial infections

Polyphor, Roche agree to develop and commercialize antibiotic for bacterial infections

Solution for enzyme-based diagnostic testing in remote locations to be exhibited by Sherwood Scientific at MEDICA 2013

Solution for enzyme-based diagnostic testing in remote locations to be exhibited by Sherwood Scientific at MEDICA 2013

INTEGRA launches new single-use waste collection bottles for its VACUSIP benchtop aspiration system

INTEGRA launches new single-use waste collection bottles for its VACUSIP benchtop aspiration system

GHIT Fund to host panel discussion to examine recent successes, setbacks in global health

GHIT Fund to host panel discussion to examine recent successes, setbacks in global health

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.